应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06821 凯莱英
交易中 01-14 15:28:47
86.200
-2.250
-2.54%
最高
92.300
最低
85.100
成交量
70.23万
今开
87.050
昨收
88.450
日振幅
8.14%
总市值
311.18亿
流通市值
23.75亿
总股本
3.61亿
成交额
6,183万
换手率
2.55%
流通股本
2,755万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元
智通财经 · 01-13 18:53
Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元
港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”
智通财经 · 01-13 10:09
港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”
凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元
新浪港股 · 01-11 16:29
凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元
Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元
智通财经网 · 01-09
Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元
每日卖空追踪 | 凯莱英 01月08日卖空量成交1.77万股,卖空比例为4.23%
市场透视 · 01-08
每日卖空追踪 | 凯莱英 01月08日卖空量成交1.77万股,卖空比例为4.23%
中欧基金葛兰2025年三季度坚守医药板块,多只标的获增持
财经杂谈 · 01-08
中欧基金葛兰2025年三季度坚守医药板块,多只标的获增持
凯莱英H股午后涨幅扩大 机构普遍看好创新药产业链的长期机会
上证快讯 · 01-07
凯莱英H股午后涨幅扩大 机构普遍看好创新药产业链的长期机会
港股创新药ETF基金涨近3%
云掌财经 · 01-07
港股创新药ETF基金涨近3%
港股异动 | CRO概念股集体走高 行业内外需共振 2026年业绩有望进入改善周期
智通财经 · 01-07
港股异动 | CRO概念股集体走高 行业内外需共振 2026年业绩有望进入改善周期
凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%
证券之星 · 01-05
凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%
凯莱英医药(06821) 2025年12月股份变动月报:股本维持不变
公告速递 · 01-05
凯莱英医药(06821) 2025年12月股份变动月报:股本维持不变
每日卖空追踪 | 凯莱英 01月02日卖空量成交4200股,卖空比例为9.13%
市场透视 · 01-02
每日卖空追踪 | 凯莱英 01月02日卖空量成交4200股,卖空比例为9.13%
凯莱英01月02日主力净流入51.9万元 散户资金抛售
市场透视 · 01-02
凯莱英01月02日主力净流入51.9万元 散户资金抛售
凯莱英:多肽项目进入中后期后对产能需求高
证券之星 · 2025-12-31
凯莱英:多肽项目进入中后期后对产能需求高
凯莱英:天津新产能匹配新业务领域
证券之星 · 2025-12-31
凯莱英:天津新产能匹配新业务领域
每日卖空追踪 | 凯莱英 12月31日卖空量成交3700股,卖空比例为2.45%
市场透视 · 2025-12-31
每日卖空追踪 | 凯莱英 12月31日卖空量成交3700股,卖空比例为2.45%
每日卖空追踪 | 凯莱英 12月30日卖空量成交5000股,卖空比例为1.36%
市场透视 · 2025-12-30
每日卖空追踪 | 凯莱英 12月30日卖空量成交5000股,卖空比例为1.36%
凯莱英12月30日遭主力抛售328.0万元
市场透视 · 2025-12-30
凯莱英12月30日遭主力抛售328.0万元
每日卖空追踪 | 凯莱英 12月29日卖空量成交4300股,卖空比例为0.89%
市场透视 · 2025-12-29
每日卖空追踪 | 凯莱英 12月29日卖空量成交4300股,卖空比例为0.89%
一周港股牛熊榜 | AI材料与有色爆发!中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%;因股份解禁,周六福暴跌24.9%、药捷安康暴跌20.5%
老虎资讯综合 · 2025-12-26
一周港股牛熊榜 | AI材料与有色爆发!中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%;因股份解禁,周六福暴跌24.9%、药捷安康暴跌20.5%
加载更多
公司概况
公司名称:
凯莱英
所属市场:
SEHK
上市日期:
--
主营业务:
凯莱英医药集团(天津)股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产(CDMO)、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":86.2,"timestamp":1768375627888,"preClose":88.45,"halted":0,"volume":702280,"delay":0,"floatShares":27553260,"shares":361000000,"eps":3.008734494023718,"marketStatus":"交易中","change":-2.25,"latestTime":"01-14 15:28:47","open":87.05,"high":92.3,"low":85.1,"amount":61826450,"amplitude":0.081402,"askPrice":86.25,"askSize":2100,"bidPrice":86.2,"bidSize":4500,"shortable":3,"etf":0,"ttmEps":3.200680569855836,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768378200000},"marketStatusCode":2,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":88.45,"dividendRate":0.01427,"openAndCloseTimeList":[[1768354200000,1768363200000],[1768366800000,1768377600000]],"volumeRatio":0.918038,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":104.04,"timestamp":1768374000000,"preClose":105.87,"halted":0,"volume":10028100,"delay":0,"premium":"-25.92"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2603688509","title":"Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688509","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603688509?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:53","pubTimestamp":1768301597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,1月9日,Schroders PLC减持凯莱英(06821)16.77万股,每股作价83.6305港元,总金额约为1402.48万港元。减持后最新持股数目为550.56万股,最新持股比例为19.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1328615791.USD","BK0132","06821","BK0239","BK1191","002821"],"gpt_icon":0},{"id":"2603575538","title":"港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575538?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:09","pubTimestamp":1768270178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股涨幅居前,截至发稿,药明康德涨8.48%,报120.2港元;凯莱英涨7.4%,报91.4港元;康龙化成涨7.13%,报24.64港元;泰格医药涨7.16%,报53港元;药明生物涨5%,报39.46港元。消息面上,1月12日晚,药明康德公布,公司全年预计实现营业收入454.56亿元,同比增长15.84%;其中,持续经营业务收入同比增长约21.40%。预计经调整归母净利润149.57亿元,同比增长约41.33%;归属于公司股东的净利润191.51亿元,同比增长约 102.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","LU0572944931.SGD","LU0819121731.USD","LU0456842615.SGD","LU1242518857.USD","03347","02359","LU0456827905.SGD","LU2495084118.USD","LU1997245094.SGD","SG9999002562.SGD","LU0588546209.SGD","LU2125910500.SGD","LU0516423091.SGD","LU0417516738.SGD","LU0039217434.USD","BK0216","LU1046422090.SGD","LU0856984785.SGD","LU1720050803.USD","LU0140636845.USD","LU0359201612.USD","LU1794554557.SGD","LU1808992512.USD","BK1610","LU2045819591.USD","SG9999002463.SGD","IE00B0JY6N72.USD","LU1997244956.HKD","BK1141","LU0181495838.USD","03759","LU0051755006.USD","LU0456846285.SGD","BK1583","LU0516422440.USD","LU3063872942.SGD","06821","LU0320764599.SGD","LU0052750758.USD","LU0708995583.HKD","LU0516422366.SGD","LU2039709279.SGD","LU0348825331.USD","LU0417516902.SGD","02269","LU1934453819.USD","LU0823426308.USD","LU1997245177.USD","BK1576"],"gpt_icon":0},{"id":"2602553587","title":"凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553587","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553587?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:29","pubTimestamp":1768120140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示,1月7日,Schroders PLC减持凯莱英(06821)26.05万股,每股作价82.7099港元,总金额约为2154.59万港元。减持后最新持股数目为574.18万股,最新持股比例为20.84%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3825365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1328615791.USD","BK0239","06821","BK1191","BK0132","002821"],"gpt_icon":0},{"id":"2602378543","title":"Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378543","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378543?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:30","pubTimestamp":1767958245,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,1月7日,Schroders PLC减持凯莱英(06821)26.05万股,每股作价82.7099港元,总金额约为2154.59万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK1191","BK0132","06821","002821","LU1328615791.USD"],"gpt_icon":0},{"id":"2601365109","title":"每日卖空追踪 | 凯莱英 01月08日卖空量成交1.77万股,卖空比例为4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601365109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601365109?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861038,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月08日,跌1.25%,卖空量成交1.77万股,较上一交易日减少66.6%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2601508673","title":"中欧基金葛兰2025年三季度坚守医药板块,多只标的获增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2601508673","media":"财经杂谈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601508673?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:05","pubTimestamp":1767841535,"startTime":"0","endTime":"0","summary":"随着公募基金2025年三季度报披露完毕,中欧基金葛兰的投资布局与调仓动向受到市场广泛关注。从整体业绩来看,三季度期间,葛兰旗下三只基金均大幅跑赢同期业绩比较基准。信立泰首次出现在中欧医疗创新前十大重仓股名单中,该个股此前二季度期间位于其隐形重仓股行列。对于行业前景与投资布局,葛兰在三季报中指出,医药行业的长期发展核心驱动力依然在于创新升级、消费复苏及国产化替代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108120245a7014cd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108120245a7014cd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1515","BK1574","BK1161","03759","09939","BK1191"],"gpt_icon":0},{"id":"2601876792","title":"凯莱英H股午后涨幅扩大 机构普遍看好创新药产业链的长期机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876792","media":"上证快讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601876792?lang=zh_cn&edition=full","pubTime":"2026-01-07 14:04","pubTimestamp":1767765869,"startTime":"0","endTime":"0","summary":"1月7日午后,凯莱英H股涨幅扩大,盘中一度涨至84.65港元/股。截至13时15分,凯莱英报83.05港元/股,涨7.37%,成交额约8265万港元。同时,凯莱英A股延续涨势。消息面上,多家机构看好创新药产业链长期机会。太平洋证券的研报显示,2026年创新药产业链景气度持续提升;海通证券研报显示,该机构看好创新药产业链长期机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107140609a4a65027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107140609a4a65027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","06978","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"2601760808","title":"港股创新药ETF基金涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760808","media":"云掌财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760808?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:58","pubTimestamp":1767765495,"startTime":"0","endTime":"0","summary":"盘面上,港股创新药表现活跃,凯莱英飙涨7%,泰格医药、昭衍新药、康方生物涨超5%,和黄医药、翰森制药、恒瑞医药等个股涨超4%。截至10:34,热门ETF——港股创新药ETF基金上涨2.85%,冲击三连涨!数据显示,港股创新药ETF基金近60日“吸金”超1亿;最新基金规模达9.39亿元。港股创新药ETF基金跟踪中证港股通创新药指数,指数编制方式更科学合理,成分股涵盖如百济神州、信达生物和药明生物等领军企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","06821","01276","06127","09926","01801","BK1161","02269","BK1191","03692","02315","00013","BK1574"],"gpt_icon":0},{"id":"2601828162","title":"港股异动 | CRO概念股集体走高 行业内外需共振 2026年业绩有望进入改善周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601828162?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:41","pubTimestamp":1767753707,"startTime":"0","endTime":"0","summary":"中泰证券认为,CRO、CDMO行业内外需共振,供给端逐步出清。兴业证券指出,受益于创新药BD出海和融资企稳回升,多家CRO新签订单逐季度加速,项目量实现双位数增长。Q4以来从实验用猴、安评报价到临床项目价格均有提升趋势,客户需求保持旺盛,展望2026年CRO业绩有望进入改善周期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","LU0052750758.USD","06127","02359","LU2242644610.SGD","LU0708995583.HKD","03759","LU1046422090.SGD","06821","BK1576","LU2125910500.SGD","03347","BK1141","LU0320764599.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2601880356","title":"凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880356","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601880356?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:45","pubTimestamp":1767624323,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,凯莱英报收于95.88元,较前一交易日上涨3.17%,最新总市值为345.74亿元。该股当日开盘93.2元,最高96.88元,最低93.04元,成交额达5.58亿元,换手率为1.84%。近日,凯莱英发布H股证券变动月报表公告。公告显示,截至2025年12月31日,公司H股和A股的法定/注册股本均无变动。H股已发行股份为27,553,260股,A股已发行股份为331,889,160股,库存股为1,151,300股。H股限制性股票计划项下本月底可能发行的股份为1,465,000股。公司呈交日期为2026年1月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK1191","161027","BK0132","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"1192366118","title":"凯莱英医药(06821) 2025年12月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1192366118","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192366118?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:54","pubTimestamp":1767603287,"startTime":"0","endTime":"0","summary":"凯莱英医药集团(天津)股份有限公司于2026年1月5日发布2025年12月股份变动月报。截至2025年12月31日,公司已发行H股27,553,260股及A股333,040,460股,合计360,593,720股,保持与上月一致。报告显示,H股与A股均无新增发行、购回及注销情况。A股库藏股数量仍为1,151,300股,本月亦未发生变动。公司于2025年4月3日通过的H股限制性股票计划本月无股份实际发行,但仍有1,465,000股限制性股票的潜在发行情形。本次月报由联席公司秘书徐向科签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"gpt_icon":0},{"id":"2600092340","title":"每日卖空追踪 | 凯莱英 01月02日卖空量成交4200股,卖空比例为9.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600092340","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600092340?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342639,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月02日,涨3.37%,卖空量成交4200股,较上一交易日增加13.51%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163508a6eb2b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163508a6eb2b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2600349092","title":"凯莱英01月02日主力净流入51.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2600349092","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600349092?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:15","pubTimestamp":1767341753,"startTime":"0","endTime":"0","summary":"01月02日, 凯莱英股价涨3.37%,报收73.60元,成交金额334.1万元,换手率0.17%,振幅3.93%,量比0.11。凯莱英今日主力资金净流入51.9万元,上一交易日主力净流出328.0万元。该股近5个交易日下跌3.92%,主力资金累计净流出521.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入165.5万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161925a6eb20be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161925a6eb20be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2595972714","title":"凯莱英:多肽项目进入中后期后对产能需求高","url":"https://stock-news.laohu8.com/highlight/detail?id=2595972714","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595972714?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司多肽产能不断扩建已经要达到4万升了,但是贵司服务的核心多肽产品玛仕度肽订单被诺泰生物抢走了一些,贵司的多肽产能是否会面临着闲置的风险?凯莱英回复:尊敬的投资者,您好!多肽项目进入中后期后对产能需求高,目前公司在多肽减重领域共服务十几个分子, 近半数处于临床Ⅱ和Ⅲ期,预计明年部分项目将进入PPQ阶段,产能需求持续增加。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06821","BK0132","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2595727110","title":"凯莱英:天津新产能匹配新业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2595727110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595727110?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司天津小分子产能紧张,为何不能分流业务到敦化小分子基地生产?本来公司产能就闲置,为何还要重复建设产能?凯莱英回复:尊敬的投资者,您好!公司需要根据项目整体情况不同匹配最佳产能,以达到效益最大化。天津新产能主要匹配增速较快的新业务领域。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","LU1328615791.USD","BK1191","06821","BK0132","BK0239"],"gpt_icon":0},{"id":"2595572201","title":"每日卖空追踪 | 凯莱英 12月31日卖空量成交3700股,卖空比例为2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595572201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595572201?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169837,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月31日,跌1.45%,卖空量成交3700股,较上一交易日减少54.32%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163643a48dc9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163643a48dc9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2595799640","title":"每日卖空追踪 | 凯莱英 12月30日卖空量成交5000股,卖空比例为1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595799640?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083436,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月30日,跌3.73%,卖空量成交5000股,较上一交易日减少81.88%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163612a48980ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163612a48980ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2595799637","title":"凯莱英12月30日遭主力抛售328.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595799637?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:15","pubTimestamp":1767082542,"startTime":"0","endTime":"0","summary":"12月30日, 凯莱英股价跌3.73%,报收72.25元,成交金额2666.8万元,换手率1.33%,振幅7.33%,量比0.83。凯莱英今日主力资金净流出328.0万元,连续4日净流出,上一交易日主力净流出67.7万元。该股近5个交易日下跌9.88%,主力资金累计净流出309.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入113.6万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161929a4896db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161929a4896db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2595768973","title":"每日卖空追踪 | 凯莱英 12月29日卖空量成交4300股,卖空比例为0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595768973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595768973?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997035,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月29日,涨1.69%,卖空量成交4300股,较上一交易日减少71.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163601a6dc4b6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163601a6dc4b6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"1102493660","title":"一周港股牛熊榜 | AI材料与有色爆发!中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%;因股份解禁,周六福暴跌24.9%、药捷安康暴跌20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493660","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102493660?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:46","pubTimestamp":1766738819,"startTime":"0","endTime":"0","summary":"24日镍概念集体走高,力勤资源、中伟新材、新疆新鑫矿业均涨幅近 9%。12月23日,周六福在港交所公告,董事会注意到公司H股价格近期出现不寻常波动。根据数据,此次药捷安康共计5名股东发生解禁,累计解禁股数达977.4万股,占比约2.46%。23日跌超18%、24日继续跌5.8%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","02617","06168","HSCEI","HSI","HSTECH","02068","02268","02245","02315","02579","01952","03939"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.1435},{"period":"1month","weight":0.145},{"period":"3month","weight":-0.0291},{"period":"6month","weight":-0.053},{"period":"1year","weight":0.9292},{"period":"ytd","weight":0.2423}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0336},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.0959},{"period":"1year","weight":0.4225},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团(天津)股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产(CDMO)、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.038783},{"month":2,"riseRate":0.5,"avgChangeRate":0.017674},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034311},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084779},{"month":5,"riseRate":0.5,"avgChangeRate":0.040294},{"month":6,"riseRate":0.5,"avgChangeRate":0.01751},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010177}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}